December 20, 2024 12:00 ET | Source: Avextra Pharma GmbH News Release Exclusive Industry Role: Avextra is the industry partner…
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic…
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute for Business Value today published its latest 'Automotive…
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15 ET | Source: Biomea Fusion, Inc. REDWOOD CITY,…
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute for Business Value today published its latest 'Automotive…
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute for Business Value today published its latest 'Automotive…
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast…
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast…
ARMONK, N.Y., Dec. 12, 2024 /PRNewswire/ -- The IBM (NYSE: IBM) Institute for Business Value today published its latest 'Automotive…
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast…